Immunohistochemical Localisation of Tissue Plasminogen Activator in Human Brain Tumours

Overview

Journal Br J Cancer

Specialty Oncology

Date 1989 Mar 1

PMID 2539181

Citations 5

Authors

A J Franks

E Ellis

Affiliations

Soon will be listed here.

Abstract

The distribution of tissue plasminogen activator (t-PA) has been studied in a series of 38 human brain tumours and two specimens of cerebral cortex, using the monoclonal antibody ESP6. t-PA was localised in vascular endothelium in the majority of tumours and both the cortical specimens, confirmed by double staining with Ulex europaeus lectin (Uel) and Factor 8-related antigen. Nineteen out of 22 high grade astrocytomas showed strong endothelial staining whereas staining was weak or absent in the four low grade astrocytomas studied. No consistent relationship was found between the pattern of staining and tumour grade in the other tumours, although strong staining of the three metastatic lesions with Uel was observed. Among the astroglial tumours only one glioblastoma showed any tumour cell staining for t-PA, which raises questions concerning the origin of t-PA producing cells derived from human gliomas in vitro. Studies of t-PA in brain tumours should take account of this vascular localisation before concluding that the activity is derived from neoplastic cells.

Citing Articles

Modulation of tissue-type plasminogen activator expression by platelet activating factor in human glioma cells.

Akai T, Niiya K, Sakuragawa N, Iizuka H, Endo S J Neurooncol. 2002; 59(3):193-8.

PMID: 12241114 DOI: 10.1023/a:1019966918589.

The hemostatic system and angiogenesis in malignancy.

Wojtukiewicz M, Sierko E, Klement P, Rak J Neoplasia. 2001; 3(5):371-84.

PMID: 11687948 PMC: 1506206. DOI: 10.1038/sj.neo.7900184.

Inhibition of tumor necrosis factor-alpha and -beta secretion by lymphokine activated killer cells by transforming growth factor-beta.

Naganuma H, Sasaki A, Satoh E, Nagasaka M, Nakano S, Isoe S Jpn J Cancer Res. 1994; 85(9):952-7.

PMID: 7961125 PMC: 5919594. DOI: 10.1111/j.1349-7006.1994.tb02974.x.

Prognostic role of urokinase-type plasminogen activator in human gliomas.

Hsu D, Efird J, Hedley-Whyte E Am J Pathol. 1995; 147(1):114-23.

PMID: 7604873 PMC: 1869896.

Prognostic significance of proteolytic enzymes in human brain tumors.

Bindal A, Hammoud M, Shi W, Wu S, Sawaya R, Rao J J Neurooncol. 1994; 22(2):101-10.

PMID: 7538161 DOI: 10.1007/BF01052886.

References

Cohadon F, Aouad N, Rougier A, Vital C, Rivel J, Dartigues J . Histologic and non-histologic factors correlated with survival time in supratentorial astrocytic tumors. J Neurooncol. 1985; 3(2):105-11. DOI: 10.1007/BF02228885. View

Unkeless J, Gordon S, Reich E . Secretion of plasminogen activator by stimulated macrophages. J Exp Med. 1974; 139(4):834-50. PMC: 2139579. DOI: 10.1084/jem.139.4.834. View

Franks A, Burrow H . In vitro heterogeneity in human gliomas. Are all transformed cells of glial origin?. Anticancer Res. 1986; 6(4):625-9. View

Presta M, Moscatelli D, Rifkin D . Purification from a human hepatoma cell line of a basic fibroblast growth factor-like molecule that stimulates capillary endothelial cell plasminogen activator production, DNA synthesis, and migration. Mol Cell Biol. 1986; 6(11):4060-6. PMC: 367172. DOI: 10.1128/mcb.6.11.4060-4066.1986. View

McLean J, Frame M, Freshney R, Vaughan P, Mackie A, Singer I . Phenotypic modification of human glioma and non-small cell lung carcinoma by glucocorticoids and other agents. Anticancer Res. 1986; 6(5):1101-6. View

Quindlen E, Bucher A . Correlation of tumor plasminogen activator with peritumoral cerebral edema. A CT and biochemical study. J Neurosurg. 1987; 66(5):729-33. DOI: 10.3171/jns.1987.66.5.0729. View

McKeever P, Smith B, TAREN J, Wahl R, KORNBLITH P, Chronwall B . Products of cells cultured from gliomas. VI. Immunofluorescent, morphometric, and ultrastructural characterization of two different cell types growing from explants of human gliomas. Am J Pathol. 1987; 127(2):358-72. PMC: 1899753. View

Jacobsen P, Jenkyn D, Papadimitriou J . Four permanent cell lines established from human malignant gliomas: three exhibiting striated muscle differentiation. J Neuropathol Exp Neurol. 1987; 46(4):431-50. DOI: 10.1097/00005072-198707000-00003. View

Fenlon S, Ellis I, Bell J, Todd J, Elston C, Blamey R . Helix pomatia and Ulex europeus lectin binding in human breast carcinoma. J Pathol. 1987; 152(3):169-76. DOI: 10.1002/path.1711520305. View

10.

Kennedy P, Watkins B, Thomas D, Noble M . Antigenic expression by cells derived from human gliomas does not correlate with morphological classification. Neuropathol Appl Neurobiol. 1987; 13(5):327-47. DOI: 10.1111/j.1365-2990.1987.tb00190.x. View

11.

Quigley J . Association of a protease (plasminogen activator) with a specific membrane fraction isolated from transformed cells. J Cell Biol. 1976; 71(2):472-86. PMC: 2109752. DOI: 10.1083/jcb.71.2.472. View

12.

Maunoury R . Establishment and characterization of 5 human cell lines derived from a series of 50 primary intracranial tumors. Acta Neuropathol. 1977; 39(1):33-41. DOI: 10.1007/BF00690383. View

13.

TUCKER W, Kirsch W, Martinez-Hernandez A, Fink L . In vitro plasminogen activator activity in human brain tumors. Cancer Res. 1978; 38(2):297-302. View

14.

Towbin H, Staehelin T, Gordon J . Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979; 76(9):4350-4. PMC: 411572. DOI: 10.1073/pnas.76.9.4350. View

15.

Rijken D, Wijngaards G, Welbergen J . Purification and partial characterization of plasminogen activator from human uterine tissue. Biochim Biophys Acta. 1979; 580(1):140-53. DOI: 10.1016/0005-2795(79)90205-8. View

16.

Laug W, Tokes Z, Benedict W, Sorgente N . Anchorage independent growth and plasminogen activator production by bovine endothelial cells. J Cell Biol. 1980; 84(2):281-93. PMC: 2110557. DOI: 10.1083/jcb.84.2.281. View

17.

McAuslan B, Hannan G, Reilly W, Stewart F . Variant endothelial cells. Fibronectin as a transducer of signals for migration and neovascularisation. J Cell Physiol. 1980; 104(2):177-86. DOI: 10.1002/jcp.1041040207. View

18.

Rijken D, Wijngaards G, Welbergen J . Relationship between tissue plasminogen activator and the activators in blood and vascular wall. Thromb Res. 1980; 18(6):815-30. DOI: 10.1016/0049-3848(80)90204-2. View

19.

Rijken D, Collen D . Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. J Biol Chem. 1981; 256(13):7035-41. View

20.

Mullins D, Rohrlich S . The role of proteinases in cellular invasiveness. Biochim Biophys Acta. 1983; 695(3-4):177-214. DOI: 10.1016/0304-419x(83)90011-2. View